Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma-Bio ServPBSV -27.16%43 Market Cap is $9.68 Mil as of Aug. 02, 2026. GuruFocus rates PBSV with a GF Score™ of 43/100 and a GF Value™ of $0.58 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 693 Healthcare Providers & Services companies, Pharma-Bio Serv ranks worse than 83.26% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pharma-Bio Serv's share price for the quarter that ended in Apr. 2026 was $0.5. Pharma-Bio Serv's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 22.90 Mil. Therefore, Pharma-Bio Serv's market cap for the quarter that ended in Apr. 2026 was $11.45 Mil.
Pharma-Bio Serv's quarterly market cap
increased
from Oct. 2025 ($12.37 Mil) to Jan. 2026 ($13.62 Mil) but then
declined
from Jan. 2026 ($13.62 Mil) to Apr. 2026 ($11.45 Mil).
Pharma-Bio Serv's annual market cap
declined
from Oct. 2023 ($19.51 Mil) to Oct. 2024 ($13.32 Mil) and
declined
from Oct. 2024 ($13.32 Mil) to Oct. 2025 ($12.37 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pharma-Bio Serv's Enterprise Value for Today is $-1.15 Mil.
Pharma-Bio Serv (OTCPK:PBSV) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pharma-Bio Serv Market Cap Related Terms
Pharma-Bio Serv Market Cap Historical Data
* Premium members only.
The historical data trend for Pharma-Bio Serv's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Pharma-Bio Serv's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma-Bio Serv Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Market Cap distribution charts can be found below:
* The bar in red indicates where Pharma-Bio Serv's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pharma-Bio Serv's Market Cap for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma-Bio Serv (PBSV) has a Market Cap of $9.68 Mil as of Aug. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pharma-Bio Serv and its competitors. According to the industry distribution chart, Pharma-Bio Serv ranks #577 out of 693 companies in the Healthcare Providers & Services industry, placing it in the top 83.3%.
Is Pharma-Bio Serv's Market Cap too high?
Pharma-Bio Serv's current Market Cap is $9.68 Mil. The Healthcare Providers & Services industry median Market Cap is 104.38. Pharma-Bio Serv's value of $9.68 Mil is 90.7% below this industry median. Based on the distribution chart, Pharma-Bio Serv ranks #577 out of 693 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pharma-Bio Serv has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma-Bio Serv's Market Cap compare to MGRX and BFRG?
According to the Healthcare Providers & Services industry distribution chart, Pharma-Bio Serv ranks #577 out of 693 companies for Market Cap. This places Pharma-Bio Serv in the lower half of its industry. The industry median Market Cap is 104.38. Pharma-Bio Serv's value of $9.68 Mil is 90.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 104.38, based on 693 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma-Bio Serv's current Market Cap of $9.68 Mil is 90.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pharma-Bio Serv and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 104.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma-Bio Serv's current Market Cap is $9.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma-Bio Serv stock overvalued right now?
Based on GuruFocus' analysis, Pharma-Bio Serv (PBSV) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.58, compared to a current price of $0.42 — trading 27.2% below its estimated fair value. The current Market Cap is $9.68 Mil and 90.7% below the Healthcare Providers & Services industry median of 104.38. Pharma-Bio Serv's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Pharma-Bio Serv (PBSV), the current Market Cap is $9.68 Mil as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma-Bio Serv (PBSV) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma-Bio Serv stock appears to be undervalued.
The current stock price of $0.42 is trading 27.2% below its estimated GF Value™ of $0.58.
GuruFocus considers Pharma-Bio Serv to be Modestly Undervalued.
Key valuation signals for PBSV:
Market Cap: $9.68 Mil
GF Value™: $0.58 vs. price of $0.42 (27.2% below fair value)
Industry Position: 90.7% below the Healthcare Providers & Services median (#577 of 693)
No single metric tells the full story. See the PBSV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.
43GF Score
Get the complete analysis for PBSV
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBSV has been successfully added to your 
